ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

PLRX Pliant Therapeutics Inc

13,79
-0,19 (-1,36%)
07 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Pliant Therapeutics Inc PLRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,19 -1,36% 13,79 01:58:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,09 13,71 14,33 13,79 13,98
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202422:11EDGAR2Form 8-K - Current report
06.5.202422:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06.5.202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.5.202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
02.4.202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
27.3.202415:23GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
12.3.202412:30GLOBEPliant Therapeutics Announces Accelerated Bexotegrast..
27.2.202422:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
27.2.202422:06EDGAR2Form 8-K - Current report
27.2.202422:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
26.2.202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
15.2.202402:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
05.2.202413:31EDGAR2Form 8-K - Current report
04.2.202421:29GLOBEPliant Therapeutics Announces Positive Safety and..
24.1.202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202414:00GLOBEPliant Therapeutics to Participate in the 42nd Annual J.P...
13.11.202322:30GLOBEPliant Therapeutics Presentations at The Liver Meeting® 2023..
09.11.202322:11EDGAR2Form 8-K - Current report
09.11.202322:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
08.11.202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
06.11.202314:00GLOBEPliant Therapeutics Presentations at the Annual Meeting of..
31.10.202321:03GLOBEPliant Therapeutics Announces Three Presentations at the..
19.10.202314:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Interim Data..
16.10.202322:05GLOBEPliant Therapeutics Appoints S. Mishima Gerhart as Chief..
03.10.202322:53EDGAR2Form 8-K - Current report
26.9.202313:34EDGAR2Form 8-K - Current report
26.9.202313:30GLOBEPliant Therapeutics Announces Positive Safety and..
25.9.202322:05GLOBEPliant Therapeutics to Host Investor Call and Webcast to..
15.9.202314:00GLOBEPliant Therapeutics Appoints Minnie Kuo as Chief Development..
11.9.202314:00GLOBEPliant Therapeutics Announces Presentations at the European..
30.8.202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
28.8.202322:05GLOBEPliant Therapeutics Announces Three Upcoming Presentations..
09.8.202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:05EDGAR2Form 8-K - Current report
09.8.202322:03GLOBEPliant Therapeutics Provides Corporate Update and Reports..
09.8.202314:00GLOBEPliant Therapeutics Announces Initiation of BEACON-IPF, a..
25.7.202314:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
21.7.202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.7.202322:06EDGAR2Form 144 - Report of proposed sale of securities
20.7.202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.7.202302:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock